Related Experiment Video

Updated: Mar 21, 2026

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

31.0K

Is complete remission key in elderly patients with AML?

Felicetto Ferrara1

  • 1Division of Hematology, Cardarelli Hospital, Via Nicolò Piccinni 6, Naples 80128, Italy.

The Lancet. Haematology
|May 3, 2016
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

822

Related Experiment Videos

Last Updated: Mar 21, 2026

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

31.0K
Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

822

Related Concept Videos

Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.5K
1.5K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

2.3K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.3K

Articles linked to this work by shared authors, journal, and citation graph.

Azacitidine-venetoclax in unfit acute myeloid leukaemia: One size does not fit all.

British journal of haematology·2026

Disease course of FLT3 mutated extramedullary acute myeloid leukemia and efficacy of gilteritinib.

Haematologica·2026

Early Ibrutinib Dose Modifications in CLL: A Post Hoc Analysis of the Real-World EVIdeNCE Study.

Cancers·2026

Impact of fitness categorization according to SIE/SIES/GITMO criteria in therapy-related and AML-MRC receiving CPX-351.

Blood advances·2026

Optimal management of elderly/old Ph+ acute lymphoblastic leukemia patients.

Haematologica·2026

Real-life management of 476 older adults with Philadelphianegative acute lymphoblastic leukemia: a Campus ALL study.

Haematologica·2026

Venetoclax in combination with cytarabine with or without idarubicin or azacitidine in children, adolescents, and young adults with relapsed or refractory acute myeloid leukaemia (VENAML): a multicentre, phase 1 expansion study.

The Lancet. Haematology·2026

A US perspective on optimising the inpatient classical haematology consultation service.

The Lancet. Haematology·2026

Autologous and allogeneic haematopoietic cell transplantation in adult patients with Hodgkin lymphoma: recommendations from the EBMT Practice Harmonisation and Guidelines Committee and Lymphoma Working Party.

The Lancet. Haematology·2026

Apixaban for the treatment of venous thromboembolic events in paediatric patients: an open-label, multicentre, randomised, controlled descriptive trial.

The Lancet. Haematology·2026

Female reproductive health-what the classical haematologist needs to know.

The Lancet. Haematology·2026

Inotuzumab ozogamicin in paediatric very high risk first B-cell acute lymphoblastic leukaemia relapse (ITCC-059): a multicentre, single-arm, phase 2 trial.

The Lancet. Haematology·2026

A Multidimensional Comparison of Psychosocial Adjustment, Functional Hearing, and Device Benefit in Adult Hearing Device Users.

Healthcare (Basel, Switzerland)·2026

Discrepancies between insertion and target gain are associated with hearing aid abandonment in Chilean older adults.

Scientific reports·2026

Embedding routine hearing health checks within existing Meals on Wheels services - A protocol for the SOUND-BITES Program pilot study.

PloS one·2026

Effect of Noise-Reduction Management Combined with Extended Postoperative Care on Patients Undergoing Laparoscopic Cholecystectomy: A Retrospective Study.

Noise & health·2026

Advances in Research on the Association between Age-Related Hearing Loss and Risk of Falls and Fractures.

Noise & health·2026

Audit of Tracheostomy Decannulation in a Suburban Tertiary Care Hospital.

Journal of the West African College of Surgeons·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us